Results 151 to 160 of about 9,301,702 (224)

Novel Imidazopyridine-Oxadiazole β‑Tubulin Inhibitors Suppress Breast Cancer Migration and Induce Caspase-3-Mediated Apoptosis. [PDF]

ACS Omega
Cakir M, Kuzu B.
europepmc   +1 more source

Effect of 1,3,4-oxadiazoles on expression of biofilm-associated bap gene in clinical isolates of multidrug-resistant Acinetobacter baumannii. [PDF]

Sci Rep
Rahimbakhsh A, Seyfahmadi M, Souldozi A, Hakimelahi R, Alikhani MY, Kafilzadeh F.   +5 more
europepmc   +1 more source

Lead Optimization: Synthesis and Biological Evaluation of Griseofulvin Derivatives as Novel SIRT6 Activators. [PDF]

ACS Med Chem Lett
Zorko T, Kogovšek J, Ciber L, Ostojić I, Maraš N, Novinec M, Štefane B.   +6 more
europepmc   +1 more source

Bis-Oxadiazole Assemblies as NO-Releasing Anticancer Agents. [PDF]

Pharmaceutics
Matnurov EM, Stebletsova IA, Larin AA, Arakelyan J, Ananyev IV, Gushchin AL, Fershtat LL, Babak MV.   +7 more
europepmc   +1 more source

Activity Profiling of Nitro-Substituted Di(Hetero)Aryl 1,3,4- and 1,2,4-Oxadiazoles: Antimicrobial, Cholinesterase Inhibition and Antioxidant Potential. [PDF]

Arch Pharm (Weinheim)
Šikorová E, Štěpánková Š, Frýbová E, Konečná K, Korbielová J, Švarcová M, Janďourek O, Pflégr V, Bősze S, Krátký M.   +9 more
europepmc   +1 more source

A novel and sustainable synthesis-functionalization strategy for the oxidative cyclization towards 2,5-disubstituted-1,3,4-oxadiazoles using bentonite-supported copper(i) iodide as a green catalyst. [PDF]

RSC Adv
Tran VQ, Tran DM, Tran MH, Tran PH, Nguyen HT.   +4 more
europepmc   +1 more source

Tri-1,3,4-Oxadiazoles Modified with Nitroimine: Balancing Energy, Sensitivity, and Thermal Stability. [PDF]

Molecules
Chen F, Yu Q, Li L, Peng K, Zhu C, Yi W.
europepmc   +1 more source

A two-decade overview of oxadiazole derivatives as promising anticancer agents. [PDF]

RSC Adv
Salem M, El-Adl K, El-Morsy A, Abulkhair HS.   +3 more
europepmc   +1 more source

Structural and computational supported development of 2,5-disubstituted-1,3,4-oxadiazole analogues as active LOX, urease, and α-glucosidase inhibitors. [PDF]

Sci Rep
Javid J, Aziz-Ur-Rehman, Iqbal J, Ahmed I, Bhatti N, Kuznetsov A, Zafar F, Ayub MA, Mohammed OA, Al-Mijalli SH, Iqbal M, Shah SAA.   +11 more
europepmc   +1 more source